Frequent Questions

What is the economic impact of the universal waste pharmaceutical rulemaking?

This proposed rule does not have any significant economic impacts on the regulated community. In addition, this action does not adversely affect small businesses. EPA estimates that the cost savings of the proposed rule will range from 33.9 million to 35.2 million per year for hospitals and reverse distributors combined. These cost savings largely reflect reduced disposal costs.

For more information, see http://www.epa.gov/epawaste/hazard/wastetypes/universal/pharm.htm

Have more questions? Submit a request